Alzheimer Disease Journal Articles

• Multimorbidity Among Community-Dwelling Older Adults How common is multimorbidity among community-dwelling older adults, and what are the risk factors?
  Age and Ageing, October 07, 2022
• Polypharmacy and HRQoL Among Patients With Chronic Disease Does polypharmacy negatively impact the psychological domain of HRQoL as well as the physical domain among patients with chronic diseases?
  Preventing Chronic Disease, September 22, 2022
• Lyme Neuroborreliosis: Known Knowns, Known Unknowns This review provides an approach to patients with neurological disorders in whom a diagnosis of Lyme neuroborreliosis is being considered. What does and does not constitute nervous system disease?
  Brain, September 21, 2022
• Care Experiences of Medicare Advantage Enrollees With AD Do Medicare Advantage enrollees with Alzheimer disease or related dementias report worse care experiences than beneficiaries without ADRD?
  Journal of the American Geriatrics Society, September 09, 2022
• Reimagining Cholinergic Therapy for Alzheimer's Disease This comprehensive review explores the pathophysiology of the basal forebrain cholinergic system, its relation to cognition, and its relevance for Alzheimer disease therapy.
  Brain, September 09, 2022
• Risk of Dementia in Patients With Inflammatory Bowel Disease Do ulcerative colitis or Crohn's disease increase the risk of dementia?
  Alimentary Pharmacology & Therapeutics, September 07, 2022
• COVID-19 Among Medicare Beneficiaries With/Without Disabilities This study found that COVID-19 incidence and hospitalization rates were disproportionately higher among disability-eligible Medicare beneficiaries than those aged 65 and over.
  Morbidity & Mortality Weekly Report, September 05, 2022
• Microdose Cannabinoid Extract Ameliorates Alzheimer's Symptoms Might cannabinoid microdosing be effective in improving memory and brain functions in mild Alzheimer disease, as this case suggests?
  Journal of Medical Case Reports, August 19, 2022
• Repurposing Atomoxetine for Neuroprotection in MCI Atomoxetine, approved for ADHD, can be repurposed as a safe and effective therapy for mild cognitive impairment and improves multiple biomarkers of Alzheimer's disease, according to this study.
  Brain, August 19, 2022
• Attitudes Toward Deprescribing Among Older Adults With Dementia Are persons with dementia willing to stop one of their regular medication if a physician advises it?
  Journal of the American Geriatrics Society, August 11, 2022
• Modifiable Risk Factors for Alzheimer Disease and Dementias This new CDC report reveals that the most common modifiable risk factors for Alzheimer disease in adults 45 and over are high blood pressure and not meeting aerobic physical activity guidelines.
  Morbidity & Mortality Weekly Report, August 10, 2022
• Is the Rise in Reported Dementia Mortality Real? Are rising trends in dementia mortality rates real, or due to an increasing tendency of physicians to report dementia as a direct cause of death on the death certificate?
  American Journal of Epidemiology, August 08, 2022
• Probabilities of Successful Development of Pain Medications This study examined factors which most influence the probability of successful development of new medications for pain. How does the perceived abuse potential of the medication impact these variables?
  Anesthesiology, August 04, 2022
• Short-term Memory Difficulties at Ages 50-75 and Dementia Risk This study found that in persons aged 50 years and older, subjective short-term memory difficulties were associated with intermediate and long-term risk of all-cause and vascular dementia.
  Age and Ageing, August 01, 2022
• Air Pollution Affects Exercise and Dementia Risk Association Engaging in regular physical activity can help reduce the risk for dementia, but the increased respiration in polluted environments may lessen the positive effect.
  Medicine and Science in Sports and Exercise, August 01, 2022
• Neuropathic Pain Prevalence and Treatment in Nursing Homes Neuropathic pain is common among nursing home residents, but many of these individuals are not receiving adequate treatment.
  Pain, July 28, 2022
• Alzheimer's Disease and Related Dementias and Heart Failure This study investigated the prevalence of heart failure in patients with Alzheimer disease and related dementias. What impact does co-occurrence of these conditions have on outcomes?
  Journal of the American Geriatrics Society, July 21, 2022
• Next-generation Antibody-based Therapies in Neurology This article reviews the biology of antibody-based therapeutics, summarizing promising new developments in their potential application in a variety of neurological diseases.
  Brain, July 08, 2022
• A Comparative Analysis of SSRIs and Fall Risk in Older Adults Do certain selective serotonin reuptake inhibitors prescribed to older adults increase the risk of falls more than others?
  Journal of the American Geriatrics Society, July 07, 2022
• Unplanned Hospital Admissions Among People With Dementia How do patterns of unplanned hospital admissions change among older persons after a diagnosis of dementia?
  Age and Ageing, July 01, 2022